Insights from Experts: Preventing and Managing CMV Post-Solid Organ Transplant
Program Overview
Join experts, Fernanda P. Silveira, MD, MS, FIDSA, FAST and Jennifer Saullo, MD, PharmD, FIDSA, as they delve into the complexities of cytomegalovirus (CMV) prevention and treatment following solid organ transplantation (SOT). Presentations will feature detailed case discussions with a focus on managing resistant and refractory disease, addressing treatment-related toxicities, and optimizing therapeutic strategies. This program is an essential primer on the scientific challenges and solutions in this critical area of transplant medicine.
Transplant specialists/surgeons, nephrologists, internal medicine, and infectious disease clinicians
Educational Objectives
Upon completion of this activity, participants should be better able to:
Employ antiviral treatments to prevent and manage cytomegalovirus (CMV) in solid organ transplant (SOT) patients
Create treatment strategies for refractory or resistant CMV in SOT patients that leverage recent advancements in antiviral therapy while minimizing side effects
Activity Faculty
Jennifer Saullo, MD, PharmD, FIDSA
Associate Professor, Department of Medicine Division of Infectious Diseases
Transplant Infectious Diseases Service
Duke University Medical Center
Durham, NC
Fernanda P. Silveira, MD, MS, FIDSA, FAST
Professor, Medicine Director, Clinical Operations
Transplant Infectious Diseases
University of Pittsburgh Medical Center
Pittsburgh, PA